The Role of Muscle Ultrasound in Assessment of Sample of Patients With Limb-girdle Muscular Dystrophy

NCT06399770 | Not Yet Recruiting

• 1 other identifier: Limb-girdle muscular dystrophy
• Study Type: observational
• Target: 50
• Locations: 0 countries
• Sites: N/A

Brief Summary

1. 1.to detect the characteristic patterns of muscle involvement in suspected cases of LGMD using muscle ultrasound
2. 2.to use the muscle ultrasound findings clinically categorized the different types of LGMD
3. 3.to correlate the muscle ultrasound findings with the findings of the other assissed scales

Conditions

Limb-girdle Muscular Dystrophy

Outcome Measures

Primary Outcomes (1)

• The role of muscle ultrasound in assessment of a sample of patients with limb-girdle muscular dystrophy

  The role of muscle ultrasound in assessment of sample of patients with LGMD

  Baseline

Interventions

Muscle ultrasound DEVICE

Role of muscle ultrasound in LGMD

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

* Patients presented with clinical manifestations suggestive of LGMD who presented with gradual progressive limb-girdle weakness ,myopathic changes on electromyography and elevated creatine phosphokinase serum level * age and sex matched healthy control group as a normal referencce

You may qualify if:

• gender : both sex are included Willingness to participate in the study and to be subjected to disease related examination and assessments Willing and able to provide informd consent

You may not qualify if:

• patients unable to give informed consent Patients with acute or subacute onset of symptoms of muscle involvement including inflammatory myopathies Patients with systemic diseases causing secondary myopathy

Sponsors & Collaborators

• Assiut University: lead

MeSH Terms

Conditions

Muscular Dystrophies, Limb-Girdle

Condition Hierarchy (Ancestors)

Muscular Dystrophies; Muscular Disorders, Atrophic; Muscular Diseases; Musculoskeletal Diseases; Neuromuscular Diseases; Nervous System Diseases; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Abanoub Bassem Fikry

CONTACT

+201210927033; Abanoubbassem2@icloud.Com

Ghaydaa Ahmed Shehata

CONTACT

+201004489683; Ghaydaa@yahoo.com

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Abanoub bassem

Study Record Dates

• First Submitted: May 1, 2024
• First Posted: May 6, 2024
• Study Start: June 1, 2024
• Primary Completion (Estimated): June 1, 2026
• Study Completion (Estimated): July 1, 2026
• Last Updated: May 6, 2024

Record last verified: 2024-05